KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Retained Earnings: 2009-2025

Historic Retained Earnings for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to -$2.1 billion.

  • Acadia Pharmaceuticals' Retained Earnings rose 11.12% to -$2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 billion, marking a year-over-year increase of 11.12%. This contributed to the annual value of -$2.2 billion for FY2024, which is 9.32% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Retained Earnings of -$2.1 billion as of Q3 2025, which was up 3.33% from -$2.2 billion recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Retained Earnings peaked at -$2.1 billion during Q1 2021, and registered a low of -$2.5 billion during Q3 2023.
  • Over the past 3 years, Acadia Pharmaceuticals' median Retained Earnings value was -$2.4 billion (recorded in 2024), while the average stood at -$2.3 billion.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Retained Earnings dropped by 14.51% in 2021 and then rose by 11.12% in 2025.
  • Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Retained Earnings stood at -$2.2 billion in 2021, then declined by 10.03% to -$2.4 billion in 2022, then decreased by 2.59% to -$2.4 billion in 2023, then grew by 9.32% to -$2.2 billion in 2024, then grew by 11.12% to -$2.1 billion in 2025.
  • Its Retained Earnings was -$2.1 billion in Q3 2025, compared to -$2.2 billion in Q2 2025 and -$2.2 billion in Q1 2025.